author-photo

Guelten Oskay-Oezcelik

Charité

19

Papers

375

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

2018 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (41)
Attentes des patientes suivies pour un cancer de l’ovaire concernant les traitements d’entretien : résultats de la cohorte française GINECO de l’enquête européenne NOGGO/ENGOT-ov22 (Expression IV)

2018 Bulletin Du Cancer
Show All
- Source
- Cite
- Save
Citations (3)
Complementary and alternative medicine for cancer patients – a survey among gynecologists in Germany

2015
Show All
- Source
- Cite
- Save
Citations (1)
Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone

2012 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (48)
Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: A Randomized Multicenter Phase II Trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (73)
A phase I trial of pemetrexed plus carboplatin in recurrent ovarian cancer

2010 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (12)
Tumor- and stromal cell-specific expression of topoisomerase IIα and HER-2/neu in primary and recurrent ovarian cancer: Results of a prospective study

2009 Molecular Medicine Reports
Show All
- Source
- Cite
- Save
Citations (1)
Nonplatinum Topotecan Combinations Versus Topotecan Alone for Recurrent Ovarian Cancer: Results of a Phase III Study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (117)
Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study

2008 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (16)
What do adjuvant and metastatic breast cancer patients (BC) expect from their doctors? Final results of a german survey in 617 patients:

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)